Home » Agenda » Day 2

Day 2

  • Auditorium 1


08:15 AM


Chair Person - To be Confirmed Shortly... 09:00 AM

KEYNOTE PANEL: OPENING PANEL DISCUSSION: Increasing inclusion, diversity and equity in clinical research: Breaking down barriers to access

  • Why diversity and inclusion in clinical trials are crucial?
  • Understanding critical barriers to minority and underserved patient communities participation in clinical trials
  • Actionable ways to improve diversity in clinical trials
  • What can the industry do to promote more diversity in the future?
  • Latest guidelines that make healthcare more inclusive

Speaker - To be Confirmed... 09:05 AM

Fda's Patient Focused Drug Development: Incorporating patient voice in drug discovery and evaluation

  • Incorporating robust and meaningful patient engagement for a more informed decision-making
  • Strategies and best practices in facilitating patient recruitment and retention in clinical trials
  • Enhance understanding and use appropriate methods to capture patient understanding of the benefits and risk outcomes
  • How to best communicate patient information to support decision-making

Speaker - To be Confirmed shortly... 09:50 AM

KEYNOTE SESSION: Just putting patients at the centre of healthcare is not enough to improve care

  • Major barriers to delivering patient-centred care
  • Focus on scaling and spreading proven interventions
  • Evidence to move forward and improve care for all patients, in all settings.

Speaker - To Be Confirmed Shortly... 10:20 AM


40 minutes Networking Refreshment Break. 

10:50 AM

PLENARY SESSION: Next-generation digital innovation in Clinical trials

  • Current trends in digital health technology that can improve clinical trial recruitment and retention
  • Understanding patient needs to really make clinical trials accessible
  • How to maximise the value of technology
  • Digital innovation on the horizon

Speaker To Be Confirmed 11:30 AM

SPONSORED SPOTLIGHT: Access to the right data at the right time: Essential real-time data for more accurate and beneficial review

  • The importance of data democratization
  • Common challenges in clinical data review that hinders clinical trials
  • Strategies in overcoming these challenges
  • How to seamlessly integrate data from a variety of sources?
  • How to improve safety review efficiencies and reduce the timeline to critical studies?

Speaker - Supporting Company - To Be Confirmed 12:00 PM

KEYNOTE PANEL: The Age of Advocacy: The importance of patient voice in the new normal

  • What it takes to get it right and how to avoid common pitfalls
  • Key priorities and opportunities for advocacy during COVID-19 and beyond
  • New ways of thinking to ensure the industry remains a credible and valuable partner now and in the future
  • Better collaboration between industry and patient organisations leads to improvements in patient care

Moderator & Panellist - To Be Confirmed 12:30 PM


1 Hour Networking Lunch Break, Follow by Round Table Discussions at 14:15 PM. 

13:15 PM

ROUND TABLE DISCUSSIONS - divided between 2 sessions of 30 mins. (5 mins. to change table) - Attendees have 2 round table options to attend

TABLE 1: Advanced analytics and digital capabilities to promote better patient outcomes and an improvedreturn on investment (ROI).

TABLE 2: Design, Identification, and Sensitivity Analysis for Patient Preference Trials

TABLE 3: Enabling clients to be active on their own health care

TABLE 4: Societal perception of collaboration between patients, their organisations, and other stakeholders

TABLE 5: A value-based approached to patient engagement

Round Table Speakers / Leaders - To Be Confirmed Shortly Round Table Discussions Time Slots -14:15 - 14:45, 14:50 - 15:20 PM


40 minutes - Networking Refreshment Break at the Exhibitors Lounge Area.

Followed by Plenary Presentations. 15:20 PM

Revolutionising the future of care through personalised healthcare

  • A need to find a more personalised way of managing healthcare for each individual.
  • Lessons learned in digital health from Covid-19
  • Areas of opportunity to prioritise focus and resources for the most impact
  • Enabling regulatory agility to provide greater personalised care

Speaker - To Be Confirmed 16:00 PM

How to sustain a meaningful patient engagement across the lifecycle of medicines: A call for Action

  • Innovations that are necessary for patient engagement to become a common practice
  • Procedures that drive stakeholder alignment.
  • Resources to mobilise human and financial means towards sustained patient engagement
  • Tools for collaborative strategic planning that enables stakeholders to make strategies and take actions towards the desired future

SPEAKER - To Be Confirmed Shortly... 16:35 PM

CLOSING PANEL DISCUSSION: Driving patient-centric care during the COVID-19 Pandemic and beyond

  • COVID-19 pandemic has highlighted the need for patient-centricity, understanding the drivers for innovation in pharma
  • Partnering with patients and placing patient well-being at the core of all initiatives
    Shifting towards disease-oriented to patient-centric
  • Innovative approaches for direct-to-patient assume significant importance for driving patient-centricity
  • Technologies that enhance the patient-centricity in pharma



Thank you for your Participation at the Patient Centricity & Collaboration World Congress 2022 Americas. 


17:55 pm
Scroll to Top